Lazard Asset Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-68,547
Closed -$623K 2177
2025
Q2
$623K Buy
+68,547
New +$505K ﹤0.01% 1438
2025
Q1
Sell
-5,382
Closed -$69K 2496
2024
Q4
$69K Sell
5,382
-2,389
-31% -$31.8K ﹤0.01% 1911
2024
Q3
$121K Sell
7,771
-17,733
-70% -$269K ﹤0.01% 1739
2024
Q2
$343K Buy
+25,504
New +$522K ﹤0.01% 1363
2024
Q1
Sell
-3,875
Closed -$74K 2285
2023
Q4
$74K Sell
3,875
-217
-5% -$3.93K ﹤0.01% 1777
2023
Q3
$65K Buy
4,092
+957
+31% +$17K ﹤0.01% 1779
2023
Q2
$59K Buy
+3,135
New +$55.9K ﹤0.01% 1778
2023
Q1
Sell
-1,042
Closed -$20K 2476
2022
Q4
$20K Hold
1,042
﹤0.01% 2132
2022
Q3
$25K Buy
+1,042
New +$32.1K ﹤0.01% 2029
2021
Q2
Sell
-2,511
Closed -$94K 2042
2021
Q1
$94K Hold
2,511
﹤0.01% 1218
2020
Q4
$67K Hold
2,511
﹤0.01% 1299
2020
Q3
$63K Buy
+2,511
New +$36.6K ﹤0.01% 1119
2020
Q2
Sell
-4,029
Closed -$36K 1740
2020
Q1
$36K Buy
+4,029
New +$24.3K ﹤0.01% 1299

Other funds holding ACH

Lazard Asset Management's ACH Position: Q3 2025 in Review

Lazard Asset Management sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 68,547 shares — an estimated $623K sold.

Lazard Asset Management first reported a position in ACH in Q1 2020 and held it in 13 quarters. The position peaked at $623K in Q2 2025. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Lazard Asset Management reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 68,547 Accendra Health shares in Q3 2025, an estimated $623K.
  • Lazard Asset Management first reported a position in Accendra Health in Q1 2020 and held it in 13 quarters.
  • Lazard Asset Management's Accendra Health position peaked at $623K in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.